| Age group/PIP subtype | Number (%) of residents |
| 65 - 75 years old (21 patients) | |
| Underuse of analgesic therapy although a pain associated condition could be identified | 7 (33.33%) |
| Nonsteroidal anti-inflammatory drugs used as first line, long-term analgesics for osteoarthritis | 6 (28.57%) |
| Long-term benzodiazepine use Long-term antipsychotic use Serum creatinine not assessed in the previous year | 5 (23.81%) |
| Nonsteroidal anti-inflammatory drugs used as first line, long-term analgesics for osteoarthritis, in residents with cardiovascular diseases | 3 (14.29%) |
| Digoxin for heart failure > 0.125mg/ day No serum potassium monitoring, although the resident was on potassium-influencing therapy | 1 (4.76%) |
| 76 - 85 years old (48 patients) | |
| Serum creatinine not assessed in the previous year | 17 (35.42%) |
| Nonsteroidal anti-inflammatory drugs used as first line, long-term analgesics for osteoarthritis, in residents with cardiovascular diseases | 15 (31.25%) |
| Nonsteroidal anti-inflammatory drugs used as first line, long-term analgesics for osteoarthritis | 14 (29.17%) |
| Long-term benzodiazepine use | 10 (20.83%) |
| Long-term antipsychotic use | 9 (18.75%) |
| > 85 years old (22 patients) | |
| Digoxin for heart failure > 0.125mg/ day | 9 (40.91%) |
| Underuse of analgesic therapy although a pain associated condition could be identified | 8 (36.36%) |
| Nonsteroidal anti-inflammatory drugs used as first line, long-term analgesics for osteoarthritis Nonsteroidal anti-inflammatory drugs used as first line, long-term analgesics for osteoarthritis, in residents with cardiovascular diseases | 7 (31.82%) |
| Long-term benzodiazepine use Serum creatinine not assessed in the previous year | 6 (27.27%) |
| Long-term antipsychotic use | 4 (18.18%) |